The peptide multiple mechanisms of action, including angiogenesis, collagen synthesis, and anti-inflammation, all contribute to accelerated healing of these tissue types
This is linked to many other comorbidities, he adds, including: Heart attack Stroke Chronic kidney disease (CKD) Non-alcoholic fatty liver disease (NAFLD) Sleep apnea (ongoing research) Fibrosis (ongoing research) The research is impressive
Moreover, there was suggestive evidence of an association between GLP-1R activation and a lower risk of SUDs
In Novo Nordisks AMY trial series, subjects experienced up to 15% body weight reduction over 68 weeks an impressive result considering it targeted only one receptor system
Doctors consider a patients comorbidities (coexisting, often chronic health conditions), as well as their goals, lifestyle habits and risk factors when deciding which option to choose